To translate the findings in vitro to human patients with fatty liver disease, we assessed ERRγ expression by immunohistochemistry and found a significant positive staining in three out of three nonalcoholic steatohepatitis (NASH) patients, where one representative result is shown (Fig 5A left). The gene discussed is ESRRG; the disease is metabolic dysfunction-associated steatohepatitis.